Nucleic acid-based tissue biomarkers of urologic malignancies.
about
Piwi-interacting RNAs in cancer: emerging functions and clinical utilityPD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomyAnalysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer.Identification of novel long non-coding RNAs in clear cell renal cell carcinoma.Epigenetic biomarkers in the blood of patients with urological malignancies.Current biomarkers for diagnosing of prostate cancer.MicroRNA expression profiling in bladder cancer: the challenge of next-generation sequencing in tissues and biofluids.Promoter methylation of the immune checkpoint receptor PD-1 (PDCD1) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomyThe emerging role of non-coding circulating RNA as a biomarker in renal cell carcinoma.PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy.CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients.MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis.Aberrant methylation of PCDH10 predicts worse biochemical recurrence-free survival in patients with prostate cancer after radical prostatectomy.Tissue-Based MicroRNAs as Predictors of Biochemical Recurrence after Radical Prostatectomy: What Can We Learn from Past Studies?MicroRNA Processing Gene Methylation and Cancer Risk.
P2860
Q28071824-EDE92AE0-FBEE-4B29-91B8-16CE2F20CBA0Q34544461-07152F46-9F8A-4C11-9F7A-D89E87B615E6Q35023641-CE92080E-251F-4C69-B19A-8B5E874742BBQ35079187-2CF94CA6-079A-418A-920A-24D284A11900Q38365422-939E1090-B5CA-4C41-887A-4C2430170E64Q38584370-A030C035-B6F2-418F-92B6-BE26F5AF1216Q38613417-9EEDB36B-5248-4BFD-87AC-CCBD68501AF9Q38794624-EE37CFC5-FB50-40A7-97C8-778279E9AB50Q38959811-8FBAD002-E185-4D41-8415-C6F18E7AF176Q39318240-D9C1C1E4-17EA-449F-9720-F29ED4C1A245Q39334962-1D93C1DE-8191-47E9-B7E5-BC2FD5458DB2Q39440371-8FFE1480-5788-477A-BA64-C45C63DD1292Q42804809-CE1FE925-E8FC-4EA8-97B4-E08C96BD1090Q47109138-A1809086-9B05-4845-88BE-FCB005970F4FQ51767607-1B5D86F6-88AA-4F32-B682-98DE577EB278
P2860
Nucleic acid-based tissue biomarkers of urologic malignancies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Nucleic acid-based tissue biomarkers of urologic malignancies.
@en
type
label
Nucleic acid-based tissue biomarkers of urologic malignancies.
@en
prefLabel
Nucleic acid-based tissue biomarkers of urologic malignancies.
@en
P2093
P2860
P1476
Nucleic acid-based tissue biomarkers of urologic malignancies.
@en
P2093
Barbara Uhl
Bernhard Ralla
Carsten Stephan
Dimo Dietrich
Glen Kristiansen
Jörg Ellinger
Sebastian Meller
P2860
P304
P356
10.3109/10408363.2014.906130
P50
P577
2014-05-30T00:00:00Z